PALIVIZUMAB — all Canadian products
4 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is PALIVIZUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02245889 | SYNAGIS | ABBVIE CORPORATION | Powder For Solution | Intramuscular | PALIVIZUMAB 50 MG | Cancelled Post Market | |
| 02245890 | SYNAGIS | ABBVIE CORPORATION | Powder For Solution | Intramuscular | PALIVIZUMAB 100 MG | Cancelled Post Market | |
| 02438372 | SYNAGIS | ASTRAZENECA CANADA INC | Solution | Intramuscular | PALIVIZUMAB 50 MG | Dormant | |
| 02438364 | SYNAGIS | ASTRAZENECA CANADA INC | Solution | Intramuscular | PALIVIZUMAB 100 MG | Dormant |
Browse other molecules: